Welcome to our dedicated page for ALT5 Sigma Corporation SEC filings (Ticker: ALTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ALT5 Sigma Corporation (NASDAQ: ALTS) files a range of reports with the U.S. Securities and Exchange Commission that document its fintech operations, digital asset treasury strategy, governance changes, and financial reporting status. On this page, investors can review ALT5’s Forms 10-K and 10-Q, along with current reports on Form 8-K and other disclosures, with AI-powered summaries that help explain key points from each filing.
ALT5’s periodic reports, such as the Form 10-K annual report and Form 10-Q quarterly reports, provide detail on its Fintech & Payments segment, $WLFI Treasury segment, and legacy biotech business. These filings describe how the company presents its digital asset payments, trading, and settlement infrastructure, as well as its holdings of $WLFI tokens and exposure to the USD1 stablecoin ecosystem. They also include discussions of risk factors, accounting policies, and segment information relevant to understanding ALTS as a fintech and digital asset-focused issuer.
The company’s Form 8-K filings offer timely updates on material events. Recent 8-Ks have covered topics such as changes in executive leadership, appointment of a new independent registered public accounting firm, Nasdaq filing delays and related communications, settlements of litigation involving unauthorized access to company information, and stockholder votes to increase authorized share capital. These reports provide context on corporate governance, control environment, and significant legal or strategic developments.
Through this SEC filings page, users can access real-time updates from EDGAR, including Form 4 insider transaction reports when available, and use AI-generated insights to quickly understand lengthy documents like 10-Ks and 10-Qs. This helps investors analyze how ALT5 manages its digital asset treasury, reports on its payments and settlement platforms, and addresses regulatory and governance matters that appear in its official filings.
ALT5 Sigma Corporation reported that stockholders approved an amendment to increase authorized common stock from 200,000,000 to 2,000,000,000 shares. The vote at the reconvened Special Meeting on October 16, 2025 passed with 56,829,178 votes for, 13,099,874 against, and 4,646 abstentions. The company plans to file the amendment with the Secretary of State of Nevada.
As context, there were 109,620,596 shares of common stock outstanding and 883,667 shares of voting preferred stock outstanding as of August 12, 2025, the record date. No other matters were voted on at the reconvened Special Meeting.
ALT5 Sigma Corporation disclosed a targeted update to prior token restrictions tied to its August 11, 2025 agreements with World Liberty Financial. The company obtained a limited waiver allowing $WLFI tokens to be pledged as collateral, lent, and staked (to the extent permitted by World Liberty Financial), while dispositions and sales remain restricted.
For tokens purchased under the Securities Purchase Agreement, this waiver applies only when prefunded warrants are exercisable in full and all related securities have an effective resale registration statement. Exercisability depends on an increase in authorized share capital, which requires shareholder approval. All other Token Prohibitions remain in effect.
ALT5 Sigma Corporation reported voting results from its Special Meeting held virtually on October 10, 2025. Stockholders voted on Proposal 1, Proposal 2, and Proposal 4. The meeting was adjourned for Proposal 3, which seeks to amend the Articles of Incorporation to increase authorized common stock from 200,000,000 to 2,000,000,000; the meeting will resume on October 16, 2025 at 1:00 p.m. Eastern Time at www.virtualshareholdermeeting.com/ALTS2025SM.
For Proposal 1 (issuance of 119,000,000 shares of common stock upon exercise of pre-funded and common stock purchase warrants held by World Liberty Financial, Inc., under the August 11, 2025 securities purchase agreement), votes were For 36,989,693; Against 12,381,062; Abstentions 6,427; Broker Non-Votes 13,867,952. For Proposal 2 (appointment of a second director selected by World Liberty Financial, Inc.), votes were For 25,091,099; Against 23,868,657; Abstentions 417,426; Broker Non-Votes 13,867,952. For Proposal 4 (approval of adjournments/postponements), votes were For 24,506,210; Against 24,464,260; Abstentions 406,712; Broker Non-Votes 13,867,952. As of August 12, 2025, outstanding shares were 109,620,596 common and 883,667 voting preferred.
Director David C. Danziger reported two stock transactions in ALT5 Sigma Corp (ALTS). On 07/02/2025 he was granted 10,000 shares of common stock at a reported price of $7.88, noted as a grant tied to his appointment to the board. Following that transaction his beneficial ownership was reported as 20,000 shares. A subsequent transaction on 08/14/2025 shows an additional 10,000 shares acquired at $7.30, keeping reported beneficial ownership at 20,000 shares. The Form 4 is signed and dated 10/09/2025, and the filer checked that the form was filed by one reporting person.
ALT5 Sigma Corporation filed an 8-K to furnish two recent press releases. On October 6, 2025, the company issued a release highlighting recent advancements in its $WLFI digital asset ecosystem, which is part of its digital asset treasury operations. On October 8, 2025, it issued a second release containing a letter to stockholders related to the upcoming Special Meeting of Stockholders on October 10, 2025.
The company emphasizes that this information is being furnished, not filed, meaning it is not subject to certain Exchange Act liabilities and is not automatically incorporated into other SEC filings. The report includes a detailed cautionary note that many statements about growth in digital asset treasury operations, adoption and trading of $WLFI tokens, and platform profitability are forward-looking and subject to risks described in its prior Form 10-K and Form 10-Q.
David C. Danziger, a director of ALT5 Sigma Corp (ALTS), filed an Initial Statement of Beneficial Ownership (Form 3) dated 07/02/2025. The filing reports no securities beneficially owned by the reporting person at the time of the statement. The form confirms the reporting relationship as a director and was filed by a single reporting person.
ALT5 Sigma Corporation is updating investors on its previously announced plan to separate into two companies and finance Alyea Therapeutics Corporation independently. A planned spin-off or similar transaction of Alyea will not take place using the earlier disclosed June 2, 2025 record date and may not occur under the previously communicated timeline. The Company states that, if it proceeds with a spin-off or similar transaction, it will later announce details such as a new record date, structure, and timing. ALT5 Sigma highlights its continued confidence in Alyea’s non-addictive pain treatment patents and potential progression to the next stage of clinical trials, and notes that it is continuing to evaluate strategic options to maximize and realize Alyea’s value.
ALT5 Sigma Corporation is soliciting shareholder votes on four proposals tied to a Private Placement that gives the Lead Investor the right to appoint a second director to the board. The board recommends shareholders vote FOR the Issuance, Appointment, Authorized Shares and Adjournment proposals. The filing shows ExodusPoint Capital Management, LP holds 5,856,700 shares, representing 5.34% of voting power. The document includes a proposed certificate amendment and standard proxy background and solicitation details. Several sections of the filing appear partially redacted or truncated, limiting visibility into full Private Placement terms, purchase price, and the exact change to authorized shares.